BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7504150)

  • 1. Detection of P glycoprotein activity on normal and leukemic CD34+ cells.
    Drenou B; Fardel O; Amiot L; Fauchet R
    Leuk Res; 1993 Dec; 17(12):1031-5. PubMed ID: 7504150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.
    Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D
    Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
    Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
    Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Thaler J; Gotwald M; Hofmann J
    Blood; 1993 Dec; 82(11):3505-7. PubMed ID: 7902138
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
    Goasguen JE; Dossot JM; Fardel O; Le Mee F; Le Gall E; Leblay R; LePrise PY; Chaperon J; Fauchet R
    Blood; 1993 May; 81(9):2394-8. PubMed ID: 8097634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells.
    te Boekhorst PA; de Leeuw K; Schoester M; Wittebol S; Nooter K; Hagemeijer A; Löwenberg B; Sonneveld P
    Blood; 1993 Nov; 82(10):3157-62. PubMed ID: 7693039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
    Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
    Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
    Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ
    Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
    Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
    Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
    Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
    Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome.
    Egudina SV; Stromskaya TP; Frolova EA; Stavrovskaya AA
    FEBS Lett; 1993 Aug; 329(1-2):63-6. PubMed ID: 8102609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
    Hanson CA; Ross CW; Schnitzer B
    Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of P-glycoprotein in normal and leukemic cells.
    Tiirikainen MI; Syrjälä MT; Jansson SE; Krusius T
    Ann Hematol; 1992 Sep; 65(3):124-30. PubMed ID: 1356449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.
    Paietta E; Andersen J; Racevskis J; Gallagher R; Bennett J; Yunis J; Cassileth P; Wiernik PH
    Leukemia; 1994 Jun; 8(6):968-73. PubMed ID: 7516029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
    Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
    Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.